to engage with industry and discuss ongoing research projects and capabilities.
MECHANISMS FOR COLLABORATION Two congressionally mandated programs—Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR)—were created to promote technological inno- vation and economic growth among small businesses through federal investment. SBIR and STTR allow small, high-tech U.S. businesses and academia the opportunity to provide innova- tive research and development solutions in response to critical DOD needs.
Five federal agencies participate in both SBIR and STTR:
• DOD. • NASA. • Department of Health and Human Services. • National Science Foundation. • Department of Energy.
Six federal agencies participate in the SBIR program only:
• Department of Agriculture. • Environmental Protection Agency. • Department of Education. • Department of Homeland Security. • Department of Transportation. • Department of Commerce.
CRADAS Te preferred vehicle for technology transfer is a cooperative research and development agreement (CRADA), which allows MRMC investigators to collaborate with scientists in indus- try and academia and work toward a common research goal. CRADAs allow federal laboratories to collaborate on R&D with nonfederal parties and are used for nondisclosure agreements, material transfer agreements and complex R&D collaborations. Visit the MRMC’s Office of Research and Technology Appli- cations (ORTA) at
http://technologytransfer.amedd.army. mil/
index.cfm to learn more about the possibility of creating a CRADA with MRMC.
MRMC also has technologies available for licensing. For licens- ing opportunities, please contact ORTA at
USArmy.Detrick.
MEDCOM-MRMC.List.ORTA@
mail.mil.
OTHER WAYS OF DOING BUSINESS Te Medical Technology Enterprise Consortium (MTEC) consists of industry, academia and other entities organized and operated through a nonprofit corporation. MTEC currently has more than 200 members and is seeking new members from the following areas:
• Small and large businesses. • Academic medical research organizations. • Not-for-profit organizations. • Nontraditional government contractors.
MRMC works with MTEC through a prototype other trans- action agreement, which provides a flexible method to combine public and private resources to focus research, prototype devel- opment and commercialization on specific shared military and civilian medical technology needs.
An other transaction agreement is a funding vehicle used by federal agencies for obtaining or advancing R&D or prototypes. It’s generally used with small businesses and nontraditional contractors, but traditional contractors can be funded through that way if certain criteria are met. Other transaction authority is not a contract or assistance agreement.
MRMC’s decision gate provides a
governance structure for the development of
products throughout the acquisition process, and features event-driven milestones that allow successful products to move along the
development pathway. HTTPS: / /
ASC.ARMY.MIL
69
SCIENCE & TECHNOLOGY
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152
